Page results
-
Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
Initial results from an early phase study testing the safety and efficacy of a new drug for multiple myeloma have shown a 100 per cent overall response rate in patients with recurrent disease who were given the clinically recommended dose of the investigational drug.
-
UCLH’s Ela Biel has won a national prize for domestics with judges noting her care in protecting vulnerable patients and using her own cancer journey to empathise with cancer patients who are often more vulnerable to and anxious about infection.
-
Your acute myeloid leukaemia (AML) treatment will be delivered within a number of comprehensive specialised services led by medical and nursing cancer care experts.
-
A new service to provide comprehensive care and support for patients living with Sickle Cell disorder is now available in the comfort of their homes thanks to a partnership between UCLH and Whittington Health NHS Trusts.
-
Specialist teams at UCLH and UCL are at the forefront of research which could bring hope to people who have been robbed of their sense of smell and taste after suffering the long-term legacy of COVID-19.
-
Acute lymphoblastic leukaemia (ALL) is a form of cancer that affects the cells in the bone marrow, the soft material inside your bones.
-
Mixed sex accommodation and privacy information for patients coming into hospital for an inpatient stay
-
This page explains what sperm banking is, how it works and how it can benefit you.
File results
-
FOI/2023/0448 - Gender, transgender, non-binary guidance/ policy for staff and patients
-
FOI/2023/0449 - Endometriosis pathway
-
FOI/2023/0450 - Pain relief options (remifentanil, entonox and sterile water injections) during labour
-
Neuroimmunology and CSF Laboratory User Handbook
-
NIHR Patient Research Experience Survey 2022-2023
-
FOI/2023/0594 - Asthma Treatment
-
FOI/2023/0614 - Communications
-
FOI/2023/0750 - Treatment for non-small cell lung cancer
-
FOI/2023/0246 - Digital services used for patient care
-
FOI/2023/0452 - Eating disorders